期刊文献+

姜黄素对乳腺癌细胞顺铂敏感性的影响 被引量:7

Effect of curcumin on sensitivity of breast cancer cells to cisplatin
下载PDF
导出
摘要 目的探讨姜黄素(curcumin)对乳腺癌细胞中顺铂(Cisplatin,CDDP)治疗敏感性的影响及其可能机制。方法 CCK-8检测、Hoechst染色观察CDDP、姜黄素单独及联合用药48 h对MCF7细胞增殖抑制和细胞凋亡的影响;Western blot分析MCF7细胞在CDDP(0、1.25、2.5、5、10、20μg/m L)、姜黄素(0、1、5、20、30、50、100μmol/L)单独及联合处理后FEN1(flap endonuclease 1)表达水平的变化;CCK-8检测沉默FEN1对MCF7细胞中CDDP敏感性的影响。结果 CDDP、姜黄素均可以剂量依赖方式抑制MCF7细胞增殖,其IC50分别为5、30μmol/L;与单独2μg/m L CDDP处理组比较,2μg/m L CDDP联合20μmol/L姜黄素、30μmol/L姜黄素处理组对细胞增殖的抑制效应明显增强[分别为(84.1±0.8)%、(51.1±0.5)%、(29.4±0.3)%,P<0.05];与单独20μmol/L姜黄素处理组比较,20μmol/L姜黄素联合2μg/m L CDDP、5μg/m L CDDP处理组对细胞增殖的抑制效应也明显增强[分别为(76.9±0.7)%、(42.4±0.3)%、(31.6±0.4)%,P<0.05];2μg/m L CDDP联合20μmol/L姜黄素组的细胞凋亡明显增强(P<0.05);与Control siRNA组比较,FEN1 siRNA+CDDP组可显著增强CDDP抑制MCF7细胞增殖的敏感性[(25.4±0.3)%vs(18.7±0.2)%,P<0.05];CDDP增殖抑制无效浓度或低浓度时,FEN1蛋白的表达随CDDP的处理剂量依赖性上调,而姜黄素可剂量依赖性下调FEN1蛋白表达;与单独CDDP和姜黄素处理组比较,2μg/m L CDDP联合20μmol/L姜黄素组可显著降低FEN1蛋白表达(P<0.05)。结论姜黄素可增强CDDP对乳腺癌细胞的敏感性,其机制与降低细胞FEN1的表达有关。 Objective To explore the effect of curcumin on the sensitivity of breast cancer cells to cisplatin( CDDP) and possible mechanism. Methods CCK-8 assay and Hoechst staining were used to observe the proliferation and apoptosis of MCF-7 cells treated with curcumin alone or in combination with CDDP for 48 h. Western blotting was used to detect the expression level of flap endonuclease 1( FEN1) in MCF7 cells treated as above. The sensitivity of FEN1-silenced MCF-7 cells to CDDP was detected by CCK-8assay. Results Both CDDP and curcumin could inhibit MCF-7 cell proliferation in a dose-dependent manner,and the IC50 values of CDDP and curcumin were 5 and 30 μmol / L,respectively. Compared with the cells treated with 2 μg / m L CDDP alone,the proliferation of the cells treated with CDDP in combination with20 or 30 μmol / L curcumin was significantly inhibited [( 84. 1 ± 0. 8) % vs( 51. 1 ± 0. 5) %,( 84. 1 ± 0. 8) %vs( 29. 4 ± 0. 3) %,respectively,P〈 0. 05]. Compared with the cells treated with curcumin alone,the proliferation of the cells treated with 20 μmol / L curcumin in combination with 2 or 5 μg / m L CDDP was also significantly inhibited [( 76. 9 ± 0. 7) % vs( 542. 4 ± 0. 3) %,( 76. 9 ± 0. 7) % vs( 31. 6 ± 0. 4) %,respectively,P〈 0. 05]. Apoptosis of the cells treated with 2 μg / m L CDDP in combination with 20 μmol / L curcumin was obviously increased( P〈 0. 05). Compared with control treatment,silencing FEN1 with siRNA could enhance the sensitivity of MCF7 cell to CDDP( P〈 0. 05). FEN1 protein was up-regulated in a dosedependent manner in the cells treated with low concentration or invalid concentration of CDDP. However,curcumin could obviously down-regulate FEN1 protein in a dose-dependent manner. Compared with the cells treated with CDDP or curcumin alone,FEN1 protein expression was significantly reduced in the cells treated with 2 μg / m L CDDP in combination with 20 μmol / L curcumin( P〈 0. 05). Conclusion Curcumin can enhance the sensitivity of breast cancer cells to CDDP,which is related with the decrease of FEN1 expression.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2016年第16期1809-1814,共6页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(31571459) 重庆市自然科学基金一般项目(CSTC2012jjA10121)~~
关键词 姜黄素 CISPLATIN Fen1 乳腺癌 curcumin cisplatin flap endonuclease 1 breast cancer
  • 相关文献

参考文献18

  • 1Wilmes A, Bielow C, Ranninger C, et al. Mechanism of cis- platin proximal tubule toxicity revealed by integrating tran- scriptomics, proteomics, metabolomics and biokinetics [ J ]. Toxicol In Vitro, 2015, 30( 1 Pt A) : 117 - 127. DOI: 10. 1016/j. tiv. 2014.10. 006.
  • 2Ugur S, Ulu R, Dogukan A, et al. The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity [ J ]. Ren Fail, 2015, 37(2) : 332 - 336. DOI: 10. 3109/0886022X. 2014. 986005.
  • 3Wang J, Zhou L, Li Z, et al. YY1 suppresses FEN1 over-ex- pression and drug resistance in breast cancer[ J]. BMC Canc- er, 2015, 15: 50. DOI:10. 1186/s12885-015-1043-1.
  • 4Balakrishnan L, Bambara R A. Flap endonuclease 1 [ J ]. Annu Rev Biochem, 2013, 82:119 - 138. DOI: 10. 1146/ annurev-biochem-072511-122603.
  • 5Abdel-Fatah T M, Russell R, Albarakati N, et al. Genomic and protein expression analysis reveals flap endonuclease 1 ( FEN1 ) as a key biomarker in breast and ovarian cancer[ J]. Mol Oncol, 2014, 8 (7) : 1326 - 1338. DOI: 10. lO16/j. molonc. 2014.04. 009.
  • 6Chereddy K K, Coco R, Memvanga P B, et al. Combined effect of PLGA and curcumin on wound healing activity [ J ]. J Control Release, 2013, 171(2) : 208 -215. DOI:10. 1016/ j. jconrel. 2013.07. 015.
  • 7Hatcher H, Planalp R, Cho J, et al. Curcumin: from ancient medicine to current clinical trials [ J ]. Cell Mol Life Sci, 2008, 65 ( 11 ) : 1631 - 1652. DOI: 10. 1007/s00018-008- 7452-4.
  • 8Chang Z, Xing J, Yu X. Cureumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway[J]. Tumour Biol, 2014, 35 (1) : 753 - 758. DOI: 10. 1007/s13277-013-1102-7.
  • 9Lv Z D, Liu X P, Zhao W J, et al. Curcumin induces apop- tosis in breast cancer ceils and inhibits tumor growth in vitro and in vivo[J]. Int J Clin Exp Pathol, 2014, 7(6) : 2818 - 2824.
  • 10Chen B, Zhang Y, Wang Y, et al. Curcumin inhibits prolif- eration of breast cancer cells through Nrf2-mediated down- regulation of Fenl expression[ J]. J Steroid Biochem Mol Bi- ol, 2014, 143 : 11 - 18. DOI: 10. 1016/j. jsbmb. 2014.01. 009.

二级参考文献20

  • 1Lyamichev V et al. Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases. Science, 1993, 260:778-783.
  • 2Harrington JJ et al. Functional domains within FEN-1 and RAD2 define a family of structure-specific endonuclease: implications for nucleotide excision repair. Genes Dev, 1994, 8:1344-1355.
  • 3Hiraoka LR et al. Sequence of human FEN-l, a structure- specific endonuclease, and chromosomal localization of the gene (FEN1) in mouse and human. Genomics, 1995, 25: 220- 225.
  • 4Emoto Met al. Structure and transcription promoter activity of mouse flap endonuclease 1 gene: Alternative splicing and bidirectional promoter. Gene, 2005, 357:47-54.
  • 5Singh Pet al. Overexpression and hypomethylation of Flap endonuclease 1 gene in breast and other cancers. Mol Cancer Res, 2008, 6:1710-1717.
  • 6Sakurai Set al. Structural basis for recruitment of human flap endonuclease 1 to PCNA. EMBO J, 2005, 24:683-693.
  • 7Dor6 AS et al. Structure of an archaeal PCNAI-PCNA2-FEN1 complex: elucidating PCNA subunit and client enzyme specificity. Nucleic Acids Res, 2006, 34:4515-4526.
  • 8Devos JM et al. Crystal structure of bacteriophage T4 5' nuclease in complex with a branched DNA reveals how flap endonuclease-1 family nucleases bind their substrates. J Biol Chem, 2007, 282:31713-31724.
  • 9Sakurai S et al. Crystallization and preliminary crystallographic analysis of the catalytic domain of human flap endonuclease 1 in complex with a nicked DNA product: use of a DPCS kit for efficient protein-DNA complex crystallization. Acta Crystallogr Sect F Struct Biol Cryst Commun, 2008, 64: 39- 43.
  • 10Larsen E et al. Early-onset lymphoma and extensive embryonic apoptosis in two domain-specific Fenl mice mutants. Cancer Res, 2008, 68:4571-4579.

同被引文献94

引证文献7

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部